Promis Neurosciences Inc (PMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,959 | -18,062 | -10,797 | -4,840 | -2,095 |
| Depreciation Amortization | 2 | 11 | 10 | 7 | 3 |
| Accounts payable and accrued liabilities | 4,002 | 2,676 | 1,518 | 492 | 227 |
| Other Working Capital | 2,227 | 5,403 | 1,621 | 466 | 565 |
| Other Operating Activity | -3,833 | -7,061 | -4,832 | -3,969 | -2,067 |
| Operating Cash Flow | $-2,562 | $-17,034 | $-12,480 | $-7,845 | $-3,367 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -2 | -2 | -2 | -2 |
| Investing Cash Flow | $N/A | $-2 | $-2 | $-2 | $-2 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 6,495 | N/A | N/A | N/A |
| Financing Cash Flow | $N/A | $6,495 | $N/A | $N/A | $N/A |
| Exchange Rate Effect | 18 | -527 | -541 | -194 | 179 |
| Beginning Cash Position | 5,876 | 16,944 | 16,944 | 16,944 | 16,944 |
| End Cash Position | 3,332 | 5,876 | 3,921 | 8,904 | 13,754 |
| Net Cash Flow | $-2,544 | $-11,068 | $-13,023 | $-8,040 | $-3,190 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,562 | -17,034 | -12,480 | -7,845 | -3,367 |
| Capital Expenditure | N/A | -2 | -2 | -2 | -2 |
| Free Cash Flow | -2,562 | -17,036 | -12,482 | -7,847 | -3,369 |